Strongyloidiasis, a parasitic disease caused by infection with the helminth Strongyloides stercoralis, currently infects up to 100 million people worldwide. However, experts believe those estimates are low, highlighting the need for targeted screening and improved diagnostic methods.

As awareness spreads, the demand for testing will increase. InBios is developing serology tests, which are considered the most sensitive method for diagnosing strongyloidiasis, in anticipation of future demand.

InBios Is Developing Rapid Tests for Strongyloidiasis

Benefits:

• useful for testing small amounts of samples
• convenient for resource-poor settings, needing no specialized equipment
• easy to use with fast results

Preliminary Evaluation Study Shows "Promising

Results"

A recent study evaluating two new InBios rapid tests showed "promising results," stating that both tests were easy to use and the results were easy to interpret.

InBios is continuing to evaluate these prototype tests to assess their performance and potential use.